GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Inventory-to-Revenue

Sernova Biotherapeutics (FRA:PSH0) Inventory-to-Revenue : 0.00 (As of Apr. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sernova Biotherapeutics's Average Total Inventories for the quarter that ended in Apr. 2025 was €0.00 Mil. Sernova Biotherapeutics's Revenue for the three months ended in Apr. 2025 was €0.00 Mil.

Sernova Biotherapeutics's Inventory-to-Revenue for the quarter that ended in Apr. 2025 stayed the same from Jan. 2025 (0.00) to Jan. 2025 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Sernova Biotherapeutics Inventory-to-Revenue Historical Data

The historical data trend for Sernova Biotherapeutics's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Inventory-to-Revenue Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sernova Biotherapeutics Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sernova Biotherapeutics's Inventory-to-Revenue

For the Biotechnology subindustry, Sernova Biotherapeutics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Inventory-to-Revenue falls into.


;
;

Sernova Biotherapeutics Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sernova Biotherapeutics's Inventory-to-Revenue for the fiscal year that ended in Oct. 2024 is calculated as

Inventory-to-Revenue (A: Oct. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Oct. 2023 ) + Total Inventories (A: Oct. 2024 )) / count ) / Revenue (A: Oct. 2024 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=N/A

Sernova Biotherapeutics's Inventory-to-Revenue for the quarter that ended in Apr. 2025 is calculated as

Inventory-to-Revenue (Q: Apr. 2025 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jan. 2025 ) + Total Inventories (Q: Apr. 2025 )) / count ) / Revenue (Q: Apr. 2025 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics  (FRA:PSH0) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sernova Biotherapeutics's Days Inventory for the three months ended in Apr. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Apr. 2025 )/Cost of Goods Sold (Q: Apr. 2025 )*Days in Period
=0/0*365 / 4
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sernova Biotherapeutics's Inventory Turnover for the quarter that ended in Apr. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Apr. 2025 ) / Average Total Inventories (Q: Apr. 2025 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines